Program areas at DTS
To further education professionals and the public on the treatment, monitoring, diagnosis and prevention of Diabetes. This was achieved by holding educational conferences, maintaining an informational website, holding an ongoing podcast with leaders in the Diabetes Technology field, maintaining a spanish/english dual-language informational website and publishing 18 technical articles about Diabetes and Diabetes Technology. Conferences held in 2024, the number of attendees and other projects are as follows:1. Surveillance error grid meeting - virtual (seg project); 1/4/2024; # of attendees: 852. Consensus report on glucagon-like peptide-1 receptor agonists as adjunctive treatment for type 1 Diabetes patients using an automated insulin delivery system (glp-1ra); 3 virtual meetings; #1: 1/17/2024, #2: 4/24/2024, #3: 8/14/2024; no. Of attendees: 193. Diabetes Technology meeting (in-person) (dtm 2024); october 15-17, 2024; no. Of attendees: 4004. The use of cgm to diagnose stage 2 t1d consensus panel; meeting #1: 10/15/2024 (in-person), 27 attendees; meeting #2: 12/12/2024 (virtual), 18 attendees5. Advanced glycation endproducts (age webinar); august 8, 2024; free webinar; no. Of attendees: 2556. Continuous glucose monitoring for chronic kidney disease & end stage kidney disease in Diabetes (cgm for ckd); 3 virtual meetings; #1: 1/30/2024, #2: 5/31/2024, #3: 8/21/2024; no. Of attendees: 15ongoing projects:1. Integration of connected Diabetes device data into the electronic health record #2 (icode-2); ongoing project to standardize and integrate insulin dosing data into the ehr.2. Diabetes research hub (drh) - ongoing project; the drh is a comprehensive data ecosystem designed to accelerate breakthroughs in Diabetes research. We empower researchers by unlocking the potential of data trapped in proprietary medical devices and health systems. By creating a secure and user-friendly platform for data collection, analysis, and collaboration, the drh fuels next-generation research using ai and ml to develop personalized and effective solutions for diabetes.3. The dcb open innovation challenge; in collaboration with Diabetes center berne; ongoing - launched on 4/1/2024 & featured at the dtm 2024 on 10/17/2024.4. Diabetes Technology report (dts podcast): dts launched an ongoing podcast with leaders in the Diabetes Technology field.5. Saluddiabetes.org; dts launched a spanish/english dual-language website that summarizes recent publications in Diabetes and health for the layperson.6. Jdst (journal of Diabetes science and Technology); published 18 technical articles about Diabetes and Diabetes Technology- large language models for Diabetes care: potentials and prospects (1/4/2024)- emerging biomarkers in the laboratory and in practice: a novel approach to diagnosing heart failure in Diabetes (1/31/2024)- advanced glycation endproducts: a marker of long-term exposure to glycemia (3/25/2024- Diabetes Technology meeting 2023 (3/25/2024)- risks of peri- and postoperative complications with glucagon-like peptide-1 receptor agonists (5/14/2024)- principles of interoperability of Diabetes devices (8/5/2024)- time to moderate and severe hyperglycemia and ketonemia following an insulin pump occlusion (9/6/2024- fda interoperability designation-creating options for people with Diabetes and pump companies: regulatory, technological, and commercial perspectives. - 9/10/2024- the Diabetes Technology Society error grid and trend accuracy matrix for glucose monitors. -10/6/2024)- the benefits of using continuous glucose monitoring to diagnose type 1 Diabetes (10/12/2024)- importance of cybersecurity/the relevance of cybersecurity to Diabetes devices: an update from Diabetes Technology Society (11/7/2024)- advanced glycation end products (ages) webinar meeting report (11/7/2024)- consensus report on glucagon-like peptide-1 receptor agonists as adjunctive treatment for individuals with type 1 Diabetes using an automated insulin delivery system (11/8/2024)- artificial intelligence to diagnose complications of Diabetes (11/22/2024)- qualitative metrics from the biomedical literature for evaluating large language models in clinical decision-making: a narrative review (11/26/2024)- consensus report on the use of continuous glucose monitoring in chronic kidney disease and Diabetes (11/29/2024)- comparison of the glycemia risk index and time in range in a case series of using automated insulin delivery to improve glycemic control in people with type 1 Diabetes and end stage kidney disease on hemodialysis (11/29/2024)- how the Diabetes research hub will modernize and enhances Diabetes data utilization (12/21/2024)
Financials for DTS
| Revenues | FYE 12/2024 | FYE 12/2023 | % Change |
|---|
| Total grants, contributions, etc. | $1,290,363 | $967,906 | 33.3% |
| Program services | $535,680 | $371,507 | 44.2% |
| Investment income and dividends | $98,426 | $38,517 | 155.5% |
| Tax-exempt bond proceeds | $0 | $0 | - |
| Royalty revenue | $0 | $0 | - |
| Net rental income | $0 | $0 | - |
| Net gain from sale of non-inventory assets | $0 | $0 | - |
| Net income from fundraising events | $0 | $0 | - |
| Net income from gaming activities | $0 | $0 | - |
| Net income from sales of inventory | $0 | $0 | - |
| Miscellaneous revenues | $1,225 | $1,194 | 2.6% |
| Total revenues | $1,925,694 | $1,379,124 | 39.6% |
Organizations like DTS
| Organization | Type | Location | Revenue |
|---|
| American Academy of Otolaryngology - Head and Neck Surgery Foundation | 501(c)(3) | Alexandria, VA | $8,436,243 |
| Connective Tissue Oncology Society | 501(c)(3) | Alexandria, VA | $1,933,129 |
| American Thyroid Association | 501(c)(3) | Alexandria, VA | $3,337,385 |
| Society for Neuro-Oncology | 501(c)(3) | Houston, TX | $5,856,544 |
| Heart Failure Society of America (HFSA) | 501(c)(3) | Rockville, MD | $7,287,906 |
| SOCIETY OF CARDIOVASCULAR COMPUTED Tomography | 501(c)(3) | Arlington, VA | $3,262,094 |
| American Academy of Optometry (AAO) | 501(c)(3) | Winter Park, FL | $8,559,259 |
| Aerospace Medical Association | 501(c)(3) | Alexandria, VA | $1,631,403 |
| International College of Surgeons | 501(c)(3) | Chicago, IL | $1,063,580 |
| National Association of the Deaf | 501(c)(3) | Silver Spring, MD | $4,585,996 |
Data update history
July 2, 2025
Posted financials
Added Form 990 for fiscal year 2024
August 12, 2024
Posted financials
Added Form 990 for fiscal year 2023
November 25, 2023
Posted financials
Added Form 990 for fiscal year 2021
July 21, 2023
Posted financials
Added Form 990 for fiscal year 2022
May 14, 2023
Used new vendors
Identified 2 new vendors, including , and
Nonprofit Types
Professional associationsBusiness and community development organizationsDisease-focused nonprofitsCharities
Issues
HealthScience and technologyDiseases and disordersCommunity improvementBusiness and industry
Characteristics
Receives government fundingTax deductible donationsAccepts online donations
General information
- Address
- 845 Malcolm Rd 5
- Burlingame, CA 94010
- Metro area
- San Francisco-Oakland-Berkeley, CA
- County
- San Mateo County, CA
- Website URL
- diabetestechnology.org/index.shtmlÂ
- Phone
- (650) 692-7100
- Facebook page
- DiabetesTechnologySocietyÂ
IRS details
- EIN
- 30-0012730
- Fiscal year end
- December
- Taxreturn type
- Form 990
- Year formed
- 2001
- Eligible to receive tax-deductible contributions (Pub 78)
- Yes
Categorization
- NTEE code, primary
- G03: Voluntary Health Associations and Medical Disciplines Professional Societies and Associations
- NAICS code, primary
- 813920: Professional Associations
- Parent/child status
- Independent
California AB-488 details
- AB 488 status
- May Operate or Solicit for Charitable Purposes
- Charity Registration status
- Current
- FTB status revoked
- Not revoked
- AG Registration Number
- 128234
- FTB Entity ID
- 2402077
- AB 488 data last updated ("as-of") date
- 2025-07-16
Free account sign-up
Want updates when DTS has new information, or want to find more organizations like Diabetes Technology Society (DTS)?
Create free Cause IQ account